The Analysis of Plasma Proteomics for Luminal A Breast Cancer

The Analysis of Plasma Proteomics for Luminal A Breast Cancer

ABSTRACT Background Breast cancer is the prevailing malignancy among women, exhibiting a discernible escalation in incidence within our nation; hormone receptor‐positive (HR+) human epidermal growth factor receptor 2‐negative (HER2−) breast cancer is the most common subtype. In this study, we aimed...

Full description

Saved in:
Bibliographic Details
Main Authors: Meimei Zhao, YongWei Jiang, Xiaomu Kong, Yi Liu, Peng Gao, Mo Li, Haoyan Zhu, Guoxiong Deng, Ziyi Feng, Yongtong Cao, Liang Ma
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Cancer Medicine
Subjects:
biomarker
early detection
luminal A breast cancer
plasma proteomics
prognosis
Online Access:https://doi.org/10.1002/cam4.70470
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items